2024

• Singer, J., Tunbridge, M., Shi, B., Perkins, G., Chai, C., Salehi, T., Sim, B., Kireta, S., Johnston, J., Akerman, A., Ying, T., Wu, H., Chadban, S., et al (2024). Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial. Vaccines, 12(6). [More Information]

2023

• Shi, B., Ying, T., Xu, J., Wyburn, K., Laurence, J., Chadban, S. (2023). Obesity is Associated With Delayed Graft Function in Kidney Transplant Recipients: A Paired Kidney Analysis. Transplant International, 36, 11107. [More Information]
• Shi, B., Ying, T., Chadban, S. (2023). Survival after kidney transplantation compared with ongoing dialysis for people over 70 years of age: A matched-pair analysis. American Journal Of Transplantation, 23(10), 1551-1560. [More Information]

2022

• Tunbridge, M., Perkins, G., Singer, J., Salehi, T., Ying, T., Grubor-Bauk, B., Barry, S., Sim, B., Hissaria, P., Chadban, S., et al (2022). Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients. Trials, 23(1). [More Information]
• Singer, J., Tunbridge, M., Perkins, G., Salehi, T., Ying, T., Wu, H., Coates, P., Chadban, S. (2022). Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin - Study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients. BMJ Open, 12(12). [More Information]
• Xu, J., D'Souza, K., Lau, N., Leslie, S., Lee, T., Yao, J., Lam, S., Sandroussi, C., Chadban, S., Ying, T., Pleass, H., Laurence, J. (2022). Staged versus concurrent native nephrectomy and renal transplantation in patients with autosomal dominant polycystic kidney disease: A systematic review. Transplantation Reviews, 36(1), 100652. [More Information]
• Singer, J., Aouad, L., Wyburn, K., Gracey, D., Ying, T., Chadban, S. (2022). The Utility of Pre- and Post-Transplant Oral Glucose Tolerance Tests: Identifying Kidney Transplant Recipients With or at Risk of New Onset Diabetes After Transplant. Transplant International, 35. [More Information]

2021

• Lai, C., Yee, S., Ying, T., Chadban, S. (2021). Biomarkers as diagnostic tests for delayed graft function in kidney transplantation. Transplant International, 34(12), 2431-2441. [More Information]
• Lee, T., D'Souza, K., Hameed, A., Yao, J., Lam, S., Chadban, S., Ying, T., Celermajer, D., Sandroussi, C., Pleass, H., et al (2021). Comparison of the effect of single vs dual antiplatelet agents on post-operative haemorrhage after renal transplantation: A systematic review and meta-analysis. Transplantation Reviews, 35(1), 100594. [More Information]
• Singer, J., Li, Y., Ying, T., Aouad, L., Gracey, D., Wyburn, K., Macia, L., Wu, H., Chadban, S. (2021). Protocol for a pilot single-centre, parallel-arm, randomised controlled trial of dietary inulin to improve gut health in solid organ transplantation: The DIGEST study. BMJ Open, 11(4). [More Information]
• Anderson, M., Ying, T., Wyburn, K., Ferguson, P., Strach, M., Grimison, P., Chadban, S., Gracey, D. (2021). Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report. BMC Urology, 21(1), 87. [More Information]

2020

• Ying, T., Shi, B., Kelly, P., Pilmore, H., Clayton, P., Chadban, S. (2020). Death after kidney transplantation: An analysis by era and time post-transplant. Journal of the American Society of Nephrology, 31(12), 2887-2899. [More Information]
• Lai, C., Ying, T., Ho, P., Wyburn, K., Gallagher, M., Chadban, S. (2020). Successful kidney transplantation in a patient with stable multiple myeloma. Internal Medicine Journal, 50(4), 492-494. [More Information]

2019

• Ying, T., Gill, J., Webster, A., Kim, S., Morton, R., Klarenbach, S., Kelly, P., Ramsay, T., Knoll, G., Pilmore, H., et al (2019). Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease-A trial protocol for the CARSK study. American Heart Journal, 214, 175-183. [More Information]
• Ying, T., Wong, G., Lim, W., Clayton, P., Kanellis, J., Pilmore, H., Campbell, S., O’Connell, P., Russ, G., Chadban, S., et al (2019). Everolimus and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Registry-based 10-year Follow-up of Five Randomized Trials. Transplantation, 103(8), 1705-1713. [More Information]

2018

• Ying, T., Wong, G., Lim, W., Kanellis, J., Pilmore, H., Campbell, S., Masterson, R., Walker, R., O'Connell, P., Russ, G., Chadban, S. (2018). De novo or early conversion to everolimus and long-term cancer outcomes in kidney transplant recipients: A trial-based linkage study. American Journal Of Transplantation, 18(12), 2977-2986. [More Information]
• Ying, T., Clayton, P., Naresh, C., Chadban, S. (2018). Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression. BMC Nephrology, 19(1), 1-9. [More Information]
• Wan, S., Ying, T., Wyburn, K., Roberts, D., Wyld, M., Chadban, S. (2018). The treatment of antibody-mediated rejection in kidney transplantation: An updated systematic review and meta-analysis. Transplantation, 102(4), 557-568. [More Information]

2015

• Ying, T., Hill, P., Desmond, M., Agar, J., Mallett, A. (2015). Fibrillary glomerulonephritis: An apparent familial form? Nephrology, 20(7), 506-509. [More Information]